SADRA THOMAS: Open Payments
NPI 1528725637 · GREAT FALLS, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,180 in 62 payments from 12 companies in 2025. Trend: 2023 $1,975 · 2024 $1,966 · 2025 $1,180
Food & beverage: $1,180
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 28 | $342 |
| ABBVIE INC. | 15 | $292 |
| AstraZeneca Pharmaceuticals LP | 3 | $150 |
| GlaxoSmithKline, LLC. | 4 | $125 |
| Novartis Pharmaceuticals Corporation | 3 | $65 |
| Janssen Biotech, Inc. | 2 | $64 |
| PFIZER INC. | 2 | $33 |
| Lilly USA, LLC | 1 | $30 |
| Alexion Pharmaceuticals, Inc. | 1 | $26 |
| UCB, Inc. | 1 | $24 |
Products named: RINVOQ, OTEZLA, SAPHNELO, BENLYSTA, SKYRIZI, TAVNEOS, COSENTYX, TREMFYA.
Industry payments across MT — which companies pay providers there.
